The functional implications of Akt activity and TGF-β signaling in tamoxifen-resistant breast cancer

Young A. Yoo, Yeul Hong Kim, Jun Suk Kim, Jae Hong Seo

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Development of acquired resistance to tamoxifen is a major clinical problem during endocrine treatment in estrogen receptor positive breast cancer. Transforming growth factor-β1 (TGF-β) has been implicated in tamoxifen-induced cellular signaling in breast cancer, and increased Akt activation is associated with tamoxifen-resistant cell types. We hypothesized that the relationship between TGF-β and Akt signaling may be involved in the development and progression of tamoxifen resistance. Tamoxifen-resistant (Tam-R) cells were established from parental MCF-7 cells by continuously exposing them to 4-hydroxytamoxifen (4-OHT). Tam-R cells were associated with a decrease in TGF-β1 secretion, TGF-β-mediated transcriptional response, and growth inhibitory effects of 4-OHT. Tam-R cells expressed significantly higher levels of phosphorylated Akt and lower levels of phosphorylated Smad 3 in both the absence and presence of 4-OHT when compared to MCF-7 cells treated with 4-OHT. Ectopic expression of constitutively active Akt (Myc-AktMyr) rendered MCF-7 cells resistant to activation by TGF-β and the growth inhibitory effects of 4-OHT, while over-expression of kinase-dead Akt (Myc-AktK179M) or LY294002 treatment of Tam-R cells enhanced TGF-β activation and blocked cell growth. These results suggest that suppression of TGF-β signaling by activated Akt is correlated with the development of tamoxifen resistance in breast cancer.

Original languageEnglish
Pages (from-to)438-447
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1783
Issue number3
DOIs
Publication statusPublished - 2008 Mar 1
Externally publishedYes

Fingerprint

Transforming Growth Factors
Tamoxifen
Breast Neoplasms
MCF-7 Cells
Growth
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Estrogen Receptors
Phosphotransferases
4,17 beta-dihydroxy-4-androstene-3-one

Keywords

  • Akt
  • Breast cancer
  • Tamoxifen
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Biophysics

Cite this

The functional implications of Akt activity and TGF-β signaling in tamoxifen-resistant breast cancer. / Yoo, Young A.; Kim, Yeul Hong; Kim, Jun Suk; Seo, Jae Hong.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1783, No. 3, 01.03.2008, p. 438-447.

Research output: Contribution to journalArticle

@article{e91541a0441a4df3a48ab83c54b18dbc,
title = "The functional implications of Akt activity and TGF-β signaling in tamoxifen-resistant breast cancer",
abstract = "Development of acquired resistance to tamoxifen is a major clinical problem during endocrine treatment in estrogen receptor positive breast cancer. Transforming growth factor-β1 (TGF-β) has been implicated in tamoxifen-induced cellular signaling in breast cancer, and increased Akt activation is associated with tamoxifen-resistant cell types. We hypothesized that the relationship between TGF-β and Akt signaling may be involved in the development and progression of tamoxifen resistance. Tamoxifen-resistant (Tam-R) cells were established from parental MCF-7 cells by continuously exposing them to 4-hydroxytamoxifen (4-OHT). Tam-R cells were associated with a decrease in TGF-β1 secretion, TGF-β-mediated transcriptional response, and growth inhibitory effects of 4-OHT. Tam-R cells expressed significantly higher levels of phosphorylated Akt and lower levels of phosphorylated Smad 3 in both the absence and presence of 4-OHT when compared to MCF-7 cells treated with 4-OHT. Ectopic expression of constitutively active Akt (Myc-AktMyr) rendered MCF-7 cells resistant to activation by TGF-β and the growth inhibitory effects of 4-OHT, while over-expression of kinase-dead Akt (Myc-AktK179M) or LY294002 treatment of Tam-R cells enhanced TGF-β activation and blocked cell growth. These results suggest that suppression of TGF-β signaling by activated Akt is correlated with the development of tamoxifen resistance in breast cancer.",
keywords = "Akt, Breast cancer, Tamoxifen, Transforming growth factor-β",
author = "Yoo, {Young A.} and Kim, {Yeul Hong} and Kim, {Jun Suk} and Seo, {Jae Hong}",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.bbamcr.2007.12.001",
language = "English",
volume = "1783",
pages = "438--447",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - The functional implications of Akt activity and TGF-β signaling in tamoxifen-resistant breast cancer

AU - Yoo, Young A.

AU - Kim, Yeul Hong

AU - Kim, Jun Suk

AU - Seo, Jae Hong

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Development of acquired resistance to tamoxifen is a major clinical problem during endocrine treatment in estrogen receptor positive breast cancer. Transforming growth factor-β1 (TGF-β) has been implicated in tamoxifen-induced cellular signaling in breast cancer, and increased Akt activation is associated with tamoxifen-resistant cell types. We hypothesized that the relationship between TGF-β and Akt signaling may be involved in the development and progression of tamoxifen resistance. Tamoxifen-resistant (Tam-R) cells were established from parental MCF-7 cells by continuously exposing them to 4-hydroxytamoxifen (4-OHT). Tam-R cells were associated with a decrease in TGF-β1 secretion, TGF-β-mediated transcriptional response, and growth inhibitory effects of 4-OHT. Tam-R cells expressed significantly higher levels of phosphorylated Akt and lower levels of phosphorylated Smad 3 in both the absence and presence of 4-OHT when compared to MCF-7 cells treated with 4-OHT. Ectopic expression of constitutively active Akt (Myc-AktMyr) rendered MCF-7 cells resistant to activation by TGF-β and the growth inhibitory effects of 4-OHT, while over-expression of kinase-dead Akt (Myc-AktK179M) or LY294002 treatment of Tam-R cells enhanced TGF-β activation and blocked cell growth. These results suggest that suppression of TGF-β signaling by activated Akt is correlated with the development of tamoxifen resistance in breast cancer.

AB - Development of acquired resistance to tamoxifen is a major clinical problem during endocrine treatment in estrogen receptor positive breast cancer. Transforming growth factor-β1 (TGF-β) has been implicated in tamoxifen-induced cellular signaling in breast cancer, and increased Akt activation is associated with tamoxifen-resistant cell types. We hypothesized that the relationship between TGF-β and Akt signaling may be involved in the development and progression of tamoxifen resistance. Tamoxifen-resistant (Tam-R) cells were established from parental MCF-7 cells by continuously exposing them to 4-hydroxytamoxifen (4-OHT). Tam-R cells were associated with a decrease in TGF-β1 secretion, TGF-β-mediated transcriptional response, and growth inhibitory effects of 4-OHT. Tam-R cells expressed significantly higher levels of phosphorylated Akt and lower levels of phosphorylated Smad 3 in both the absence and presence of 4-OHT when compared to MCF-7 cells treated with 4-OHT. Ectopic expression of constitutively active Akt (Myc-AktMyr) rendered MCF-7 cells resistant to activation by TGF-β and the growth inhibitory effects of 4-OHT, while over-expression of kinase-dead Akt (Myc-AktK179M) or LY294002 treatment of Tam-R cells enhanced TGF-β activation and blocked cell growth. These results suggest that suppression of TGF-β signaling by activated Akt is correlated with the development of tamoxifen resistance in breast cancer.

KW - Akt

KW - Breast cancer

KW - Tamoxifen

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=39149108820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39149108820&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2007.12.001

DO - 10.1016/j.bbamcr.2007.12.001

M3 - Article

VL - 1783

SP - 438

EP - 447

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 3

ER -